Albemarle (NYSE:ALB) had its price objective reduced by Jefferies Group to $150.00 in a research note published on Friday morning, The Fly reports. Jefferies Group currently has a buy rating on the specialty chemicals company’s stock.

Several other research firms have also recently weighed in on ALB. Deutsche Bank cut Albemarle from a buy rating to a hold rating in a research note on Tuesday, November 14th. Robert W. Baird restated a hold rating and set a $135.00 target price on shares of Albemarle in a research note on Wednesday, November 1st. Royal Bank of Canada boosted their target price on Albemarle from $149.00 to $155.00 and gave the stock an outperform rating in a research note on Friday, November 10th. Nomura boosted their target price on Albemarle to $159.00 and gave the stock an outperform rating in a research note on Friday, November 10th. Finally, Zacks Investment Research upgraded Albemarle from a hold rating to a buy rating and set a $157.00 target price for the company in a research note on Tuesday, October 17th. Ten research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $127.78.

Shares of Albemarle (NYSE ALB) traded down $1.90 on Friday, hitting $116.01. The stock had a trading volume of 4,262,737 shares, compared to its average volume of 1,332,663. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35. The stock has a market cap of $13,028.54, a PE ratio of 15.01, a PEG ratio of 1.55 and a beta of 1.69. Albemarle has a fifty-two week low of $90.35 and a fifty-two week high of $144.99.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.01. The firm had revenue of $755.00 million during the quarter, compared to analysts’ expectations of $732.19 million. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. The firm’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 earnings per share. research analysts forecast that Albemarle will post 4.46 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is 16.56%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC acquired a new position in Albemarle during the second quarter worth approximately $11,681,000. Sumitomo Life Insurance Co. acquired a new position in Albemarle during the third quarter worth approximately $1,703,000. Vanguard Group Inc. increased its position in Albemarle by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,501,329 shares of the specialty chemicals company’s stock worth $1,319,389,000 after buying an additional 213,530 shares during the period. Hardman Johnston Global Advisors LLC increased its position in Albemarle by 1.9% during the third quarter. Hardman Johnston Global Advisors LLC now owns 285,837 shares of the specialty chemicals company’s stock worth $38,962,000 after buying an additional 5,430 shares during the period. Finally, Advisory Services Network LLC increased its position in Albemarle by 43.7% during the second quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock worth $134,000 after buying an additional 387 shares during the period. 88.07% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Albemarle (ALB) PT Lowered to $150.00” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/albemarle-alb-pt-lowered-to-150-00/1815922.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

The Fly

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.